What is he best known for?
The fields of study he is best known for:
- Surgery
- Internal medicine
- Cancer
Olivier R. Busch mainly investigates Surgery, Randomized controlled trial, Internal medicine, Pancreas and Retrospective cohort study.
His research integrates issues of Odds ratio and General surgery in his study of Surgery.
His Randomized controlled trial research includes elements of Borderline resectable, Clinical trial, Laparoscopy and Pancreatic cancer.
As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Gastroenterology and frequently concerns with Esophagus, Interquartile range and Esophageal disease.
His Pancreas research incorporates themes from Duodenum, Treatment outcome and Adenocarcinoma.
His Retrospective cohort study study integrates concerns from other disciplines, such as Distal pancreatectomy, Cancer, Colorectal cancer and Endoscopy.
His most cited work include:
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial (970 citations)
- Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. (657 citations)
- Preoperative Biliary Drainage for Cancer of the Head of the Pancreas (653 citations)
What are the main themes of his work throughout his whole career to date?
Olivier R. Busch spends much of his time researching Surgery, Internal medicine, Radiology, Pancreatic cancer and Gastroenterology.
Within one scientific family, he focuses on topics pertaining to General surgery under Surgery, and may sometimes address concerns connected to Pancreas.
His work on Scintigraphy as part of general Radiology research is frequently linked to In patient, bridging the gap between disciplines.
Olivier R. Busch focuses mostly in the field of Retrospective cohort study, narrowing it down to matters related to Pancreatic fistula and, in some cases, Odds ratio.
His Randomized controlled trial research is multidisciplinary, incorporating elements of Clinical trial, Quality of life and Endoscopy.
His Pancreaticoduodenectomy study combines topics from a wide range of disciplines, such as Pancreatectomy and Adenocarcinoma.
He most often published in these fields:
- Surgery (51.07%)
- Internal medicine (27.32%)
- Radiology (17.34%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (27.32%)
- Surgery (51.07%)
- Pancreatic cancer (15.68%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Surgery, Pancreatic cancer, Gastroenterology and Pancreatic fistula.
His work in Surgery addresses subjects such as Incidence, which are connected to disciplines such as Percutaneous.
His Pancreatic cancer study also includes
- Radiology most often made with reference to Chemotherapy,
- Lymph node and related Lymph,
- FOLFIRINOX together with Folinic acid.
His biological study spans a wide range of topics, including Carcinoma and Long term outcomes.
His Pancreatic fistula course of study focuses on Odds ratio and Meta-analysis and Confidence interval.
The concepts of his Retrospective cohort study study are interwoven with issues in Neoadjuvant therapy, Propensity score matching and Cohort study.
Between 2018 and 2021, his most popular works were:
- Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2) : a multicentre, patient-blinded, randomised controlled phase 2/3 trial (150 citations)
- Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial. (141 citations)
- Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial (132 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
Surgery, Pancreatic cancer, Internal medicine, Retrospective cohort study and Randomized controlled trial are his primary areas of study.
As part of his studies on Surgery, Olivier R. Busch often connects relevant areas like Incidence.
His work deals with themes such as Gemcitabine, Chemotherapy, FOLFIRINOX and Hazard ratio, Confidence interval, which intersect with Pancreatic cancer.
Olivier R. Busch combines subjects such as Gastroenterology, Hepatectomy and Perihilar Cholangiocarcinoma with his study of Internal medicine.
The various areas that Olivier R. Busch examines in his Randomized controlled trial study include Functional recovery, Relative risk and Clinical trial.
His study focuses on the intersection of Percutaneous and fields such as Anastomosis with connections in the field of Quality of life.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
